Boston Scientific Corp
NYSE: BSX
▲
28.10
+0.24
+0.86%
1 Day
-
Open
27.92
-
Previous Close
27.86
-
Volume (Avg)
8.18M (6.83M)
-
Day's Range
27.71-28.12
-
52Wk Range
19.67-28.51
-
Market Cap.
38.48B
-
Dividend Rate ( Yield)
-
-
Beta
1.07
-
Shares Outstanding
1.37B
-
P/E Ratio (EPS)
90.91 (0.31)
Top Stories
-
WEX Survey Reveals CFOs' Thoughts On Future Of Payments
The Street 3 days agoHere are Friday's top research calls, including downgrades for Ford, Synaptics and Western Digital, and an upgrade for Boston Scientific. Here are Thursday's top research calls, including an upgrade for AK Steel, and downgrades for FirstEnergy, Hess and ...
-
Boston Scientific (BSX) Announces CE Mark for Vercise Gevia Deep Brain Stimulation System
StreetInsider -
Boston Scientific (BSX) Up 4.4% Since Earnings Report: Can It Continue?
NASDAQ -
Ireland's most powerful women: Hall of fame
Irish Independent -
Boston Scientific, St. Jude Can't Beat UC Patent Claims
Law 360 4 hrs agoLaw360, Los Angeles (May 31, 2017, 7:14 PM EDT) -- The Regents of the University of California can continue to bring patent infringement claims against St. Jude Medical and Boston Scientific Corp. over a surgical method to treat irregular heart rhythms ...
-
Interventional Cardiology and Peripheral Vascular Devices Market Growth, Trends and Overview for the by 2022
screenny.com -
Survey Says: Here Are the 4 Most-Liked Life Science CEOs
biospace.com -
These are the highest-rated CEOs in the Boston area, according to Glassdoor
The Business Journal -
Survey: Boston Scientific’s Mahoney is 3rd-most-liked CEO
MassDevice -
Drug-Eluting Stents - Global Strategic Business Report 2017 - Leading Players are Abbott Laboratories, Boston Scientific, and Medtronic
GlobeNewswire -
America's top-rated CEO isn't a household name
CBS News -
Addressing the Challenges in Primary and Secondary Stroke Prevention: Cardiology and Neurology Come to Grips
medscape.org -
Recalled Catheters All Approved Through FDA 510(k) Clearance Protocol
Lawyers and Settlements -
Basilea Announces The Licensing Deal With Pfizer Inc (NYSE:PFE) For Antifungal Cresemba® (isavuconazole) For Europe, Turkey, Russia And Israel
journaltranscript.com -
Will Boston Scientific Corporation’s (BSX) Earnings Grow Over The Next Year?
Simply Wall St 5 days ago -
Balloon Catheters Market to Surpass US$ 5.5 Billion Threshold by 2025, with North America positioned as Growth Engine
abnewswire.com -
SmarTrend Watching for Potential Pullback in Shares of Boston Scientific After 2.00% Gain
mysmartrend.com -
Battery Longevity From Cardiac Resynchronization Therapy Defibrillators
Medscape News
